Nurse Practitioner, Psychiatric/Mental Health · Roanoke, VA
NPI
1992868657
Since 2006
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3505 Brambleton Ave
Roanoke, VA, 24018
Phone (540) 512-9754
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
798 services
Medicare patients, 2024
52
Average age 75
Drug cost, 2024
$1.6M
1,939 prescriptions
Company payments, 2025
$1,037
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pamela A Ruppel was code G2212 (prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or), 424 times for 11 patients. In total Pamela A Ruppel billed 798 services in 18 codes, and Medicare paid $43K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 424 | 11 | $20.75 | $8,797 |
| 99215 Office E&M - Established | Office | 123 | 12 | $113.57 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 94 | 13 | $10.59 | $996 |
| 99214 Office E&M - Established | Office | 27 | 14 | $76.93 | $2,077 |
| 99308 SNF E&M | Facility | 25 | 11 | $42.60 | $1,065 |
| 99307 SNF E&M | Facility | 19 | 11 | $26.10 | $496 |
By year: 2022 $159K for 2,133 services; 2023 $52K for 922 services; 2024 $43K for 798 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pamela A Ruppel prescribed most often to Medicare patients was Spravato (Esketamine Hcl), with 819 prescriptions and refills. In total Pamela A Ruppel wrote 1,939 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spravato Esketamine Hcl | 819 | 819 | 36 | $1.2M |
| Diazepam Generic | 112 | 112 | Under 11 | $237 |
| Lamotrigine Generic | 52 | 96 | Under 11 | $141 |
| Bupropion Xl Bupropion Hcl | 51 | 137 | 11 | $1,898 |
| Clonazepam Generic | 36 | 36 | Under 11 | $85.6 |
| Buspirone Hcl Generic | 35 | 51 | Under 11 | $828 |
| Gabapentin Generic | 33 | 47 | Under 11 | $398 |
| Clonidine Hcl Generic | 29 | 45 | Under 11 | $82.46 |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 25 | 47 | Under 11 | $1,561 |
| Quetiapine Fumarate Generic | 25 | 51 | Under 11 | $382 |
| Caplyta Lumateperone Tosylate | 24 | 24 | Under 11 | $38K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 23 | 37 | Under 11 | $82.19 |
| Ingrezza Valbenazine Tosylate | 23 | 23 | Under 11 | $195K |
| Vyvanse Lisdexamfetamine Dimesylate | 23 | 27 | Under 11 | $11K |
| Lorazepam Generic | 22 | 22 | Under 11 | $68.98 |
Brand drugs: 1,023 claims; generic drugs: 916 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pamela A Ruppel $1,037 ($1,037 in general payments such as food, travel and fees) from 13 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $291.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 9 | $291 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 10 | $175 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $109 |
| Lundbeck LLC | 5 | $96.23 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $86.19 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $53 |
| Abbvie Inc. ABBV | 2 | $48.19 |
| Collegium Pharmaceutical, Inc. COLL | 2 | $42.87 |
| Axsome Therapeutics, Inc. AXSM | 2 | $39.39 |
| Aimmune Therapeutics, Inc. | 1 | $33.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.